Should administration of coenzyme Q10 be recommended to patients with congestive heart failure?

Clinical Pharmacology and Therapeutics

Volumn 96, Issue 6, 2014, Pages 647-649

  Reidenberg, M M ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COUNTERFEIT DRUG; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEVALONIC ACID; PRESCRIPTION DRUG; UBIDECARENONE; UBIQUINONE;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CONGESTIVE HEART FAILURE; DEVICE SAFETY; DRUG APPROVAL; DRUG BIOAVAILABILITY; DRUG EFFICACY; HEALTH CARE COST; HUMAN; MICELLE; PATIENT SAFETY; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; REVIEW; ANALOGS AND DERIVATIVES; BLOOD; DIET SUPPLEMENTATION; DRUG COST; ECONOMICS; HEART FAILURE;

DIETARY SUPPLEMENTS; DRUG COSTS; HEART FAILURE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; UBIQUINONE;

EID: 84925554305     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/clpt.2014.166     Document Type: Review

References (11)

1. Mortensen, S.A. and Mortensen, A.L. The mitochondria in heart failure: a target for coenzyme Q10 therapy? Clin. Pharmacol. Ther. 96, 645-647 (2014).
2. Mortensen, S.A. et al. The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure. Results from the Q-SYMBIO study. Eur. J. Heart Fail. Suppl. 12 (suppl.), S21 (2013).
3. Morisco, C., Trimarco, B. & Condorelli, M. Effect of coenzyme Q10 therapy in patients with congestive heart failure: a long-term multicenter randomized study. Clin. Invest. 71 (suppl.), S134-S136 (1993).
4. Levy, H. & Kohlhaas, H. Considerations for supplement with coenzyme Q10 during statin therapy. Ann. Pharmacother. 40, 290-294 (2006).
5. Schulz, C., Obermüller-Jevic, U.C., Hasselwander, O., Bernhardt, J. & Biesalski, H.K. Comparison of the relative bioavailability of different coenzyme Q10 formulations with a novel solubilizate (Solu Q10). Int. J. Food Sci. Nutr. 57, 546-555 (2006).
6. Gavura, S. Coenzyme Q10 for heart failure: the hype and the science (20 June 2013).
7. Kettawan, A. et al. The quality control assessment of commercially available coenzyme Q10-containing dietary and health supplements in Japan. J. Clin. Biochem. Nutr. 41, 124-131 (2007).
8. Monakhova, Y.B., Ruge, I., Kuballa, T., Lerch, C. & Lachenmeier, D.W. Rapid determination of coenzyme Q10 in food supplements using 1H NMR spectroscopy. Int. J. Vitam. Nutr. Res. 83, 67-72 (2013).
9. Reidenberg, M.M. & Conner, B.A. Counterfeit and substandard drugs. Clin. Pharmacol. Ther. 69, 189-193 (2001).
10. Schultz, K.F., Altman, D.G. & Moher, D. for the CONSORT group. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomized trials. BMJ 340, c332 (2010).
11. World Health Organization. Prequalification of medicines by WHO. Fact sheet 278 (updated January 2013).